亞洲知識產權資訊網為知識產權業界提供一個一站式網上交易平台，協助業界發掘知識產權貿易商機，並與環球知識產權業界建立聯繫。無論你是知識產權擁有者正在出售您的知識產權，或是製造商需要購買技術以提高操作效能，又或是知識產權配套服務供應商，你將會從本網站發掘到有用的知識產權貿易資訊。
Potent small molecule xanthine oxidase inhibitors for the treatment of gout/hyperuricemia
技術應用
- Compared to currently approved drugs, DHNB is a safe, effective, and stable XO inhibitor with similar potency as current therapies used to reduce uric acid production, but with much lower toxicity. Therefore, it is suitable for long term use to treat and/or prevent hyperuricemia and gout.- DHNB binds to the XO enzyme with high specificity. It may be used alone or in combination with traditional drugs to enhance efficacy and prevent drug resistance.- DHNB, but not other XO inhibitors, has beneficial antioxidant properties.- BCM researchers have developed novel small molecule XO inhibitors based on the chemical structure of DHNB.
詳細技術說明
None
國家/地區
美國
欲了解更多信息，請點擊 這裡
